Clinical trial
Effect of Vitamin D3 Supplementation on Insulin Resistance and Cardiovascular Risk Factors in People at High Risk of Type 2 Diabetes and Cardiovascular Disease (The DIR Study)
NCT01889810 is registered in ClinicalTrials.gov with Queen's University, Belfast as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Vitamin D3 Supplementation on Insulin Resistance and Cardiovascular Risk Factors in People at High Risk of Type 2 Diabetes and Cardiovascular Disease (The DIR Study)
- Lead sponsor
- Queen's University, Belfast
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 31, 2013
- Completion date
- June 30, 2016
- Enrollment
- 81 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
insulin resistance, pre-diabetes, sub-optimal vitamin d status